Stool, blood (hepatic and renal functions), urine samples and ECG of pre and post-treatment were assayed for safety evaluation of rifaximin in diarrhea patients.

• 治疗前后查血、尿、大便常规，肝功、肾功生化和心电图用于安全性评价。